These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 21639142)

  • 1. Crystal structure of highly glycosylated human leukocyte elastase in complex with an S2' site binding inhibitor.
    Hochscherf J; Pietsch M; Tieu W; Kuan K; Abell AD; Gütschow M; Niefind K
    Acta Crystallogr F Struct Biol Commun; 2018 Aug; 74(Pt 8):480-489. PubMed ID: 30084397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust anti-inflammatory activity of genistein against neutrophil elastase: a microsecond molecular dynamics simulation study.
    Nayak SS; Sundararajan V
    J Biomol Struct Dyn; 2023; 41(21):11612-11628. PubMed ID: 36705087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved relaxed complex scheme for receptor flexibility in computer-aided drug design.
    Amaro RE; Baron R; McCammon JA
    J Comput Aided Mol Des; 2008 Sep; 22(9):693-705. PubMed ID: 18196463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase.
    Steinbrecher T; Case DA; Labahn A
    J Med Chem; 2006 Mar; 49(6):1837-44. PubMed ID: 16539369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
    Yavin EJ; Eisenstein M; Fridkin M
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected active-site flexibility in the structure of human neutrophil elastase in complex with a new dihydropyrimidone inhibitor.
    Hansen G; Gielen-Haertwig H; Reinemer P; Schomburg D; Harrenga A; Niefind K
    J Mol Biol; 2011 Jun; 409(5):681-91. PubMed ID: 21549129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the dynamics and ligand-specific interactions in the human leukocyte elastase through molecular dynamics simulations.
    Estácio SG; Moreira R; Guedes RC
    J Chem Inf Model; 2011 Jul; 51(7):1690-702. PubMed ID: 21639142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining docking and molecular dynamic simulations in drug design.
    Alonso H; Bliznyuk AA; Gready JE
    Med Res Rev; 2006 Sep; 26(5):531-68. PubMed ID: 16758486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular recognition of RNA: challenges for modelling interactions and plasticity.
    Fulle S; Gohlke H
    J Mol Recognit; 2010; 23(2):220-31. PubMed ID: 19941322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexible docking and design.
    Rosenfeld R; Vajda S; DeLisi C
    Annu Rev Biophys Biomol Struct; 1995; 24():677-700. PubMed ID: 7663131
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.